Meg Tirrell
Amgen boosts 2013 forecast after third-quarter sales rise
NEW YORK - Amgen Inc., the biotechnology company that completed its $10.4 billion acquisition of Onyx Pharmaceuticals Inc. this month, boosted its 2013 forecast...
Amgen’s quarterly revenue beats analysts’ estimates on top drugs
NEW YORK -- Amgen Inc., the world’s largest biotechnology company by revenue, reported second quarter sales that topped analysts’ estimates on growth of top...
Amgen says ovarian cancer drug meets goal of late-stage study
NEW YORK - Amgen Inc., the world’s largest biotechnology company by sales, said its experimental drug for recurrent ovarian cancer met a late-stage study...











